Get the Stockscreener App
0.484
13.59%
0.0579
Ispecimen Inc stock is traded at $0.484, with a volume of 448.47K.
It is up +13.59% in the last 24 hours and down -42.17% over the past month.
iSpecimen Inc is a technology-driven company focused on connecting life science researchers who need human biofluids, solid tissues, and hematopoietic stem and immune cells for their research, with the available biospecimens. The company generates revenue by procuring various specimens from hospitals, laboratories, and other supply sites. Geographically, it has a presence in the Americas; Europe, the Middle East, Africa, and Asia Pacific, which majority, comes from the Americas.
See More
Previous Close:
$0.4261
Open:
$0.3869
24h Volume:
448.47K
Relative Volume:
0.07
Market Cap:
$4.73M
Revenue:
$10.39M
Net Income/Loss:
$-9.52M
P/E Ratio:
-0.0253
EPS:
-19.12
Net Cash Flow:
$-6.02M
1W Performance:
-16.59%
1M Performance:
-42.17%
6M Performance:
-54.77%
1Y Performance:
-89.10%
1-Day Range:
$0.3869
$0.5077
1-Week Range:
$0.3869
$0.5799
52-Week Range:
$0.3869
$4.44
Ispecimen Inc Stock (ISPC) Company Profile
Name
Ispecimen Inc
Sector
Industry
Phone
781-301-6700
Address
8 CABOT ROAD, WOBURN
Compare ISPC with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ISPC
Ispecimen Inc
|
0.484 | 4.16M | 10.39M | -9.52M | -6.02M | -19.12 |
|
TMO
Thermo Fisher Scientific Inc
|
586.07 | 220.72B | 43.74B | 6.58B | 6.11B | 17.31 |
|
DHR
Danaher Corp
|
226.98 | 160.62B | 24.27B | 3.50B | 5.02B | 4.8589 |
|
IDXX
Idexx Laboratories Inc
|
752.14 | 57.96B | 4.17B | 1.03B | 940.22M | 12.61 |
|
A
Agilent Technologies Inc
|
153.60 | 42.88B | 6.79B | 1.22B | 1.09B | 4.2644 |
|
IQV
Iqvia Holdings Inc
|
228.18 | 38.30B | 15.90B | 1.28B | 2.21B | 7.2842 |
Ispecimen Inc Stock (ISPC) Latest News
iSpecimen Faces Nasdaq Delisting Notice for Stock Price - MSN
LifeMD (NASDAQ:LFMD) and iSpecimen (NASDAQ:ISPC) Head to Head Contrast - Defense World
iSpecimen receives Nasdaq notice for minimum bid price deficiency By Investing.com - Investing.com Nigeria
iSpecimen Inc. (ISPC) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
iSpecimen (ISPC) Stock Price, Quote, News & History - Benzinga
iSpecimen receives Nasdaq notice for minimum bid price deficiency - Investing.com
[DEF 14A] iSpecimen Inc. Definitive Proxy Statement - Stock Titan
[8-K] iSpecimen Inc. Reports Material Event | ISPC SEC FilingForm 8-K - Stock Titan
How iSpecimen Inc. stock reacts to inflationary pressuresOptions Play & Free Expert Verified Stock Movement Alerts - newser.com
Can iSpecimen Inc. stock maintain growth trajectory2025 Price Action Summary & Safe Entry Trade Reports - newser.com
Will iSpecimen Inc. stock maintain momentum in 2025Portfolio Return Report & Community Trade Idea Sharing - newser.com
[Form 3] iSpecimen Inc. Initial Statement of Beneficial Ownership - Stock Titan
Will iSpecimen Inc. stock deliver consistent dividendsMarket Risk Analysis & Long-Term Safe Investment Plans - newser.com
What does recent volatility data suggest for iSpecimen Inc.July 2025 Summary & Expert Approved Momentum Trade Ideas - newser.com
How buybacks impact iSpecimen Inc. stock valueSell Signal & Technical Analysis for Trade Confirmation - newser.com
Predicting iSpecimen Inc. trend using moving averagesOil Prices & Risk Managed Investment Signals - newser.com
ISpecimen Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2025 - MarketScreener
[10-Q] iSpecimen Inc. Quarterly Earnings Report | ISPC SEC FilingForm 10-Q - Stock Titan
iSpecimen Inc. stock momentum explainedMarket Risk Report & Safe Entry Momentum Tips - newser.com
Why iSpecimen Inc. stock could see breakout soonStop Loss & Weekly High Return Opportunities - newser.com
Published on: 2025-11-15 14:05:23 - newser.com
Sector ETF performance correlation with iSpecimen Inc.Weekly Investment Report & Growth Focused Stock Reports - newser.com
iSpecimen Delays Q3 2025 10-Q Filing - TipRanks
Real time breakdown of iSpecimen Inc. stock performanceQuarterly Portfolio Review & Low Volatility Stock Suggestions - newser.com
Reviewing CVS Health (NYSE:CVS) and iSpecimen (NASDAQ:ISPC) - Defense World
Ispecimen Inc Stock (ISPC) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.35%
1.41%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):